-
COST-EFFECTIVENESS ASSESSMENT OF 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV20) AMONG OLDER ADULTS IN THE PHILIPPINES
Aug 11, 2026, 17:16 PM -
DIAGNOSTIC PATHWAYS, HEALTHCARE RESOURCE USE, AND PREDIAGNOSTIC TREATMENT BURDEN IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): A REAL-WORLD COHORT STUDY IN JAPAN
Aug 11, 2026, 17:16 PM -
PATIENT OUT-OF-POCKET BURDEN AND BETWEEN-CLASS COPAYMENT HETEROGENEITY FOR INNOVATIVE CARDIOMETABOLIC PHARMACOTHERAPY IN HUNGARY, 2020-2025
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN IN PATIENTS WITH MYELOFIBROSIS: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
DRIVERS OF CROSS-JURISDICTIONAL VARIATION IN HTA RECOMMENDATIONS FOR OLAPARIB ACROSS ONCOLOGY INDICATIONS: EVIDENCE FROM ENGLAND, SCOTLAND, CANADA, AND AUSTRALIA
Aug 11, 2026, 17:16 PM -
ASSESSING THE PUBLIC HEALTH IMPACT OF DOSTARLIMAB FOR DMMR/MSI-H ADVANCED OR RECURRENT ENDOMETRIAL CANCER IN BRAZIL: QALY RESULTS FROM A BRAZILIAN PUBLIC HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
EXPLORING THE ECONOMIC BURDEN OF CHRONIC KIDNEY DISEASE FROM SAUDI PERSPECTIVE: A MULTI-STAKEHOLDER FOCUS GROUP STUDY OF POLICYMAKERS AND PAYERS
Aug 11, 2026, 17:16 PM -
ASSOCIATION BETWEEN EVEROLIMUS TIME-IN-THERAPEUTIC RANGE AND NEPHROTOXICITY IN ADULT LUNG TRANSPLANT RECIPIENTS
Aug 11, 2026, 17:16 PM -
FERTILITY INTENTIONS, CONCERNS AND SERVICE PREFERENCES AMONG WOMEN IN HONG KONG: FOCUS GROUP FINDINGS INFORMING A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF HOME-BASED CARDIAC REHABILITATION. A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
ARTIFICIAL INTELLIGENCE AND HEALTH INEQUITY: A TARGETED LITERATURE REVIEW OF BIAS ARISING FROM HISTORICAL HEALTHCARE DATA (2020-2026)
Aug 11, 2026, 17:16 PM -
TOWARDS DEVICE-FOCUSED JOINT CLINICAL ASSESSMENT: COMPARING SUBMISSION TEMPLATES FOR MEDICAL DEVICES AND MEDICINAL PRODUCTS
Aug 11, 2026, 17:16 PM -
INFORMING FUTURE FUNDING DECISIONS: A REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
BENCHMARKING AI-SUPPORTED EVIDENCE SYNTHESIS TOOLS FOR HEALTH TECHNOLOGY ASSESSMENT (HTA) EVIDENCE GENERATION: A COMPARATIVE ASSESSMENT ACROSS THE EVIDENCE LIFECYCLE
Aug 11, 2026, 17:16 PM -
VARIABILITY IN DRUG-DRUG INTERACTION DATABASES AND ITS IMPLICATIONS FOR CLINICAL DECISION SUPPORT IN ONCOLOGY: A CROSS-SECTIONAL PRESCRIPTION AUDIT FROM INDIA
Aug 11, 2026, 17:16 PM -
DEFINING HUMAN-IN-THE-LOOP IN AI-AUGMENTED SCREENING: A MULTI-LARGE LANGUAGE MODEL COMPARATIVE STUDY IN RARE DISEASE
Aug 11, 2026, 17:16 PM -
REAL-WORLD SELF-CARE BEHAVIORS AND HEALTHCARE APPLICATION UTILIZATION FOR DIABETES PREVENTION AND MANAGEMENT AMONG JAPANESE INDIVIDUALS WITH PREDIABETES: AN INTEGRATED ANALYSIS OF WEB-BASED SURVEY AND MOBILITY LOG DATA
Aug 11, 2026, 17:16 PM -
COMPREHENSIVE SOCIETAL RETURN ON INVESTMENT OF PHARMACEUTICALS FOR MULTIPLE SCLEROSIS: A LIFETIME MARKOV MODEL
Aug 11, 2026, 17:16 PM -
COST-PER-RESPONDER ANALYSIS OF RITLECITINIB VERSUS BARICITINIB IN SEVERE ALOPECIA AREATA: A SPANISH HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
FROM PICO TO DOSSIER: EVALUATING A SOURCE-GROUNDED EVIDENCE-VALIDATION LAYER FOR EVIDENCE TRACEABILITY AND CONTRADICTION DETECTION IN HTA-READY CLAIMS
Aug 11, 2026, 17:16 PM
